SLC28A3 and pancreatic neoplasm: The aberrant expression of hCNT3 was observed in pancreatic tumors and pancreatic cancer cell lines and is of high relevance for pancreatic cancer patients given its ability to transport a large variety of nucleoside-derived drugs and, more importantly, gemcitabine for solid tumors (Stecula et al., 2017).